ICAM1 anticorps (C-Term)
-
- Antigène Voir toutes ICAM1 Anticorps
- ICAM1 (Intercellular Adhesion Molecule 1 (ICAM1))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ICAM1 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu
- Attributs du produit
- CD54 (ICAM-1, Intercellular Adhesion Molecule 1, Human Rhinovirus Receptor, Precursor, BB2, Major Group Rhinovirus Receptor, P3.58)
- Purification
- Purified by immunoaffinity chromatography.
- Immunogène
- Peptide mapping at the C-terminal region of the human ICAM-1 identical to the related rat and mouse sequence.
- Isotype
- IgG
- Top Product
- Discover our top product ICAM1 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with sterile dH2O.
- Buffer
- Supplied as a lyophilized powder from PBS, pH 7.4, 5 % BSA, 0.05 % thimerosal, 0.05 % sodium azide.
- Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
- Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- ICAM1 (Intercellular Adhesion Molecule 1 (ICAM1))
- Autre désignation
- CD54 (ICAM1 Produits)
- Synonymes
- anticorps BB2, anticorps CD54, anticorps P3.58, anticorps Icam-1, anticorps Ly-47, anticorps MALA-2, anticorps ICAM, anticorps ICAM-1, anticorps ICAM1, anticorps intercellular adhesion molecule 1, anticorps intercellular adhesion molecule-1, anticorps ICAM1, anticorps Icam1, anticorps ICAM-1
- Classe de substances
- Viral Protein
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis, Regulation of Leukocyte Mediated Immunity, Thromboxane A2 Receptor Signaling
-